Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 5Withdrawn 1Unknown 1Recruiting 1Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 2Other hematologic neoplasm 1Head & Neck 1Breast 1

Conditions

Head and Neck Neoplasms 101Squamous Cell Carcinoma of Head and Neck 76Oropharyngeal Neoplasms 19Carcinoma, Squamous Cell 16Thyroid Neoplasms 15Carcinoma, Non-Small-Cell Lung 12Breast Neoplasms 11Carcinoma 10Neoplasms 9Mouth Neoplasms 9Lung Neoplasms 9Laryngeal Neoplasms 9Tongue Neoplasms 8Stomach Neoplasms 7Salivary Gland Neoplasms 7Neoplasm Metastasis 7Prostatic Neoplasms 6Ovarian Neoplasms 6Nasopharyngeal Carcinoma 6Hypopharyngeal Neoplasms 6Uterine Cervical Neoplasms 5Urinary Bladder Neoplasms 5Thyroid Carcinoma, Anaplastic 5Small Cell Lung Carcinoma 5Melanoma 5Esophageal Neoplasms 5Pancreatic Neoplasms 4Mucositis 4Carcinoma, Renal Cell 4Xerostomia 3

Interventions

parathyroid hormone-related peptide (1-36) 1Parathyroid Hormone-Related Protein 1Parathyroid Hormone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Osteoporosis × Head & Neck × Clear all
NCT01333267 2014-12-05

One Week Comparison Study of PTH and PTHrP Infusions

University of Pittsburgh

Phase 1 Withdrawn
Head & Neck

Humoral Hypercalcemia Of Malignancy, Bone Diseases, Endocrine, Endocrine System Diseases, Hyperparathyroidism, Musculoskeletal Diseases, Osteoporosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡